By Fineline Cube 
US biotech leader Amgen (NASDAQ: AMGN) announced a USD 900 million investment to expand its manufacturing operations in Ohio. This strategic move is expected to create 750 new jobs, bringing the total employment opportunities from the initiative to 750 and elevating Amgen’s cumulative investment in Central Ohio to over USD 1.4 billion.
Ohio Presence and Future Plans
Amgen established its Ohio presence in June 2021 with plans to build a cutting-edge biomanufacturing facility in the region. This latest investment underscores the company’s commitment to enhancing its manufacturing capabilities and contributing to the local economy.
Economic Impact
Since the enactment of the Tax Cuts and Jobs Act of 2017, Amgen has channeled nearly USD 5 billion in direct capital expenditures within the United States. These investments are estimated to have generated an additional USD 12 billion in downstream economic output for the US economy, highlighting Amgen’s significant role in driving economic growth and innovation.-Fineline Info & Tech